Christopher S Elliott, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Elliott’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94018 · Current
Licensed to practise in California · since 2006 · expires 2027-07-31 · Ohio State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$56,937
Medicare paid this office $56,937 for 366 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 196 | $13,757 | $52 |
| Return visit (30+ min) | 76 | $7,024 | $75 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 25 | $5,089 | $130 |
| New patient visit (30+ min) | 71 | $4,667 | $66 |
| New patient visit (45+ min) | 23 | $2,533 | $110 |
See all 11 services
| Short return visit (20+ min) | 196 | $13,757 | $52 |
| Return visit (30+ min) | 76 | $7,024 | $75 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 25 | $5,089 | $130 |
| New patient visit (30+ min) | 71 | $4,667 | $66 |
| New patient visit (45+ min) | 23 | $2,533 | $110 |
| Diagnostic exam of bladder and urethra using an endoscope | 17 | $1,354 | $68 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $1,215 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,020 | $85 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $419 | $35 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $271 | $15 |
| Electronic assessment of bladder emptying | 32 | $189 | $6 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
366 Original Medicare patients in 2024. Average age 70 · Under 65 22% · 85 and older 11% · Women 31% · Also on Medicaid 76% · Health risk score 1.77. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 73% · Diabetes 45% · Chronic kidney disease 26% · Depression 26% · Coronary heart disease 24% · Heart failure 18% · Cancer 15% · Atrial fibrillation 15% · COPD 14% · Dementia 12% · Stroke 9%.
The office billed $687,669, Medicare allowed $78,808 and paid $56,937; for 738 services of 63 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 366 | 738 | 70 | 1.77 | $687,669 | $56,937 |
| 2023 | 348 | 692 | 69 | 1.73 | $597,828 | $53,603 |
| 2022 | 377 | 655 | 70 | 1.55 | $496,547 | $47,883 |
| 2021 | 356 | 705 | 68 | 1.87 | $615,457 | $56,917 |
| 2020 | 233 | 514 | 66 | 2.14 | $461,976 | $40,252 |
| 2019 | 294 | 705 | 67 | 2.10 | $682,933 | $62,950 |
| 2018 | 165 | 272 | 68 | 1.84 | $205,828 | $20,442 |
| 2017 | 259 | 649 | 66 | 1.89 | $516,779 | $50,792 |
| 2016 | 273 | 706 | 66 | 1.83 | $529,219 | $56,685 |
| 2015 | 330 | 873 | 67 | 1.93 | $585,082 | $58,413 |
| 2014 | 377 | 881 | 66 | 1.55 | $514,740 | $55,411 |
| 2013 | 352 | 1,014 | 66 | 1.59 | $565,907 | $72,543 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 191 | $13,642 | $52 |
| Return visit (30+ min) | 72 | $8,056 | $82 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 25 | $4,482 | $132 |
| New patient visit (30+ min) | 44 | $3,030 | $69 |
| New patient visit (45+ min) | 16 | $1,936 | $121 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 18 | $1,810 | $101 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $904 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $824 | $43 |
| Insertion of device into abdomen with pressure and urine flow rate study | 19 | $610 | $32 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 19 | $302 | $16 |
| Electronic assessment of bladder emptying | 49 | $285 | $6 |
2022: 5 services
| Short return visit (20+ min) | 246 | $17,775 | $53 |
| Return visit (30+ min) | 110 | $9,698 | $79 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 18 | $3,655 | $141 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $621 | $56 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $514 | $27 |
2021: 13 services
| Short return visit (20+ min) | 223 | $15,245 | $54 |
| Return visit (30+ min) | 91 | $8,707 | $85 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 19 | $3,558 | $148 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $1,392 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,378 | $125 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,226 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $1,194 | $41 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $987 | $62 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $864 | $27 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $436 | $36 |
| Short return visit | 13 | $369 | $28 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $207 | $17 |
| Electronic assessment of bladder emptying | 16 | $74 | $5 |
2020: 13 services
| Exam with injections of chemical for destruction of bladder using an endoscope | 18 | $4,164 | $149 |
| Return visit (30+ min) | 62 | $4,080 | $58 |
| Short return visit (20+ min) | 66 | $2,735 | $37 |
| Telephone medical discussion with physician, 21-30 minutes | 32 | $2,371 | $70 |
| Telephone medical discussion with physician, 11-20 minutes | 40 | $2,087 | $43 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 20 | $1,930 | $97 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,448 | $66 |
| Aspiration of bladder with insertion of bladder tube to skin | 11 | $1,239 | $113 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $721 | $38 |
| Insertion of device into abdomen with pressure and urine flow rate study | 20 | $700 | $35 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $407 | $23 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 20 | $319 | $16 |
| Electronic assessment of bladder emptying | 22 | $88 | $4 |
2019: 13 services
| Return visit (30+ min) | 91 | $6,349 | $62 |
| Short return visit (20+ min) | 113 | $5,385 | $41 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 23 | $5,105 | $142 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 38 | $3,768 | $99 |
| New patient visit (45+ min) | 27 | $2,107 | $78 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $1,640 | $63 |
| New patient visit (30+ min) | 27 | $1,609 | $60 |
| Insertion of stent in ureter using an endoscope | 11 | $1,603 | $146 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,551 | $91 |
| Insertion of device into abdomen with pressure and urine flow rate study | 39 | $1,380 | $35 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $892 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 39 | $588 | $15 |
| Electronic assessment of bladder emptying | 50 | $205 | $4 |
2018: 10 services
| Short return visit (20+ min) | 71 | $3,456 | $46 |
| Return visit (30+ min) | 38 | $2,967 | $71 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $2,377 | $149 |
| New patient visit (45+ min) | 14 | $1,492 | $107 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $1,256 | $114 |
| New patient visit (30+ min) | 14 | $949 | $68 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $784 | $71 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $399 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $186 | $17 |
| Electronic assessment of bladder emptying | 24 | $133 | $5 |
2017: 11 services
| Return visit (30+ min) | 85 | $5,685 | $56 |
| Short return visit (20+ min) | 119 | $4,817 | $35 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 17 | $3,853 | $148 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 34 | $3,837 | $113 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $2,881 | $85 |
| New patient visit (45+ min) | 15 | $1,681 | $112 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,392 | $82 |
| Insertion of device into abdomen with pressure and urine flow rate study | 34 | $1,164 | $34 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 34 | $509 | $15 |
| Electronic assessment of bladder emptying | 55 | $291 | $4 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 13 | $188 | $14 |
2016: 9 services
| Return visit (30+ min) | 103 | $8,058 | $62 |
| Short return visit (20+ min) | 119 | $5,961 | $42 |
| Diagnostic exam of bladder and urethra using an endoscope | 44 | $4,615 | $94 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 26 | $2,530 | $97 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 11 | $2,078 | $148 |
| Simple change of bladder tube | 29 | $1,506 | $35 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 27 | $923 | $34 |
| Insertion of device into abdomen with pressure and urine flow rate study | 25 | $878 | $35 |
| Electronic assessment of bladder emptying | 38 | $186 | $5 |
2015: 14 services
| Return visit (30+ min) | 93 | $6,238 | $57 |
| Short return visit (20+ min) | 126 | $5,994 | $40 |
| Simple change of bladder tube | 59 | $5,951 | $38 |
| Diagnostic exam of bladder and urethra using an endoscope | 44 | $4,980 | $94 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 28 | $2,415 | $86 |
| Aspiration of bladder with insertion of bladder tube to skin | 12 | $1,341 | $112 |
| Insertion of device into abdomen with pressure and urine flow rate study | 37 | $1,296 | $35 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 37 | $1,226 | $33 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,143 | $88 |
| Biopsy of prostate gland | 11 | $1,007 | $92 |
| Simple insertion of temporary bladder tube | 21 | $847 | $22 |
| Electronic assessment of bladder emptying | 66 | $332 | $5 |
| Ultrasound scan of pelvic region through rectum | 11 | $327 | $30 |
| Review by radiologist of urinary bladder image | 11 | $156 | $14 |
2014: 15 services
| Simple change of bladder tube | 68 | $7,964 | $43 |
| Return visit (30+ min) | 107 | $7,704 | $59 |
| Short return visit (20+ min) | 127 | $5,190 | $38 |
| Diagnostic exam of bladder and urethra using an endoscope | 38 | $3,775 | $94 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 28 | $2,254 | $80 |
| New patient visit (45+ min) | 15 | $1,608 | $107 |
| Biopsy of prostate gland | 15 | $1,369 | $91 |
| Insertion of device into abdomen with pressure and urine flow rate study | 28 | $995 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 27 | $842 | $31 |
| Simple insertion of temporary bladder tube | 19 | $703 | $24 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $590 | $35 |
| Ultrasound scan of pelvic region through rectum | 18 | $520 | $29 |
| Ultrasonic guidance for needle placement | 15 | $449 | $30 |
| Electronic assessment of bladder emptying | 61 | $291 | $5 |
| Review by radiologist of urinary bladder image | 11 | $154 | $14 |
2013: 15 services
| Simple change of bladder tube | 63 | $8,500 | $44 |
| Short return visit (20+ min) | 124 | $6,892 | $41 |
| Return visit (30+ min) | 81 | $5,970 | $62 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $5,414 | $100 |
| New patient visit (45+ min) | 40 | $3,371 | $84 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 33 | $2,845 | $86 |
| New patient visit (30+ min) | 28 | $1,851 | $66 |
| Biopsy of prostate gland | 11 | $1,331 | $111 |
| Insertion of device into abdomen with pressure and urine flow rate study | 33 | $1,141 | $35 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 33 | $1,105 | $33 |
| Simple insertion of temporary bladder tube | 16 | $702 | $26 |
| Electronic assessment of bladder emptying | 102 | $643 | $6 |
| Ultrasound scan of pelvic region through rectum | 16 | $495 | $29 |
| Simple bladder irrigation and/or instillation | 13 | $400 | $31 |
| Ultrasonic guidance for needle placement | 11 | $346 | $29 |
Medicaid work
$7,549 in 2024
Medicaid paid $7,549 for 3,907 billed services this clinician did in 2024, up to 101 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 573 | $2,623 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 215 | $1,577 |
| Return visit (30+ min) | 170 | $1,242 |
| Change of cystostomy tube; simple | 61 | $882 |
| Hospital outpatient clinic visit for assessment and management of a patient | 65 | $796 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 59 | $221 |
| Service | 164 | $125 |
| New patient visit (30+ min) | 13 | $47 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 70 | $29 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 15 | $8 |
| Pain severity quantified; pain present (COA) (ONC) | 21 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 51 | $0 |
| 2024 | 3,907 | 20 | 101 | $7,549 |
| 2023 | 1,573 | 13 | 80 | $4,517 |
| 2022 | 857 | 5 | 59 | $6,043 |
| 2021 | 517 | 4 | 36 | $6,126 |
| 2020 | 113 | 3 | 22 | $1,492 |
| 2019 | 400 | 4 | 23 | $4,241 |
| 2018 | 483 | 6 | 40 | $4,872 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 611 | $2,324 |
| Return visit (30+ min) | 203 | $989 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 192 | $579 |
| Hospital outpatient clinic visit for assessment and management of a patient | 30 | $362 |
| Service | 72 | $196 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 84 | $67 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 55 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 54 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 19 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 31 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 113 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 41 | $0 |
2022
| Short return visit (20+ min) | 510 | $2,550 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 196 | $1,637 |
| Return visit (30+ min) | 125 | $828 |
| Change of cystostomy tube; simple | 14 | $619 |
| Service | 12 | $409 |
2021
| Short return visit (20+ min) | 336 | $3,833 |
| Return visit (30+ min) | 151 | $1,414 |
| Service | 16 | $546 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 14 | $334 |
2020
| Return visit (30+ min) | 54 | $776 |
| Short return visit (20+ min) | 47 | $495 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 12 | $221 |
2019
| Service | 69 | $2,285 |
| Return visit (30+ min) | 124 | $829 |
| Short return visit (20+ min) | 183 | $730 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 24 | $396 |
2018
| Short return visit (20+ min) | 266 | $1,594 |
| Service | 45 | $1,535 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 62 | $780 |
| Return visit (30+ min) | 41 | $380 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 56 | $332 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $251 |
Drugs they prescribed that Part D paid
$399,975
Pharmacies billed $399,975 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
587 generic and 405 brand-name prescriptions · $399,975 in drug cost · 73 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 304 | $319,047 | $1,049 |
| Gemtesa | 37 | $47,209 | $1,276 |
| Oxybutynin Chloride Er | 280 | $7,293 | $26 |
| Mirabegron Er | 14 | $5,928 | $423 |
| Renacidin | 31 | $5,607 | $181 |
See all 16 drugs
| Myrbetriq | 304 | $319,047 | $1,049 |
| Gemtesa | 37 | $47,209 | $1,276 |
| Oxybutynin Chloride Er | 280 | $7,293 | $26 |
| Mirabegron Er | 14 | $5,928 | $423 |
| Renacidin | 31 | $5,607 | $181 |
| Trospium Chloride Er | 11 | $2,906 | $264 |
| Tolterodine Tartrate Er | 22 | $2,330 | $106 |
| Potassium Citrate Er | 21 | $1,884 | $90 |
| Trospium Chloride | 23 | $1,700 | $74 |
| Nitrofurantoin | 27 | $943 | $35 |
| Finasteride | 50 | $619 | $12 |
| Estradiol | 16 | $552 | $34 |
| Amitriptyline | 12 | $446 | $37 |
| Tamsulosin | 51 | $390 | $8 |
| Cephalexin | 15 | $139 | $9 |
| Sulfamethoxazole-Trimethoprim | 17 | $69 | $4 |
Year by year
| 2024 | 992 | 215 | None | 41% | $399,975 |
| 2023 | 928 | 211 | 0% (0) | None | $430,729 |
| 2022 | 871 | 200 | 0% (0) | 39% | $357,453 |
| 2021 | 925 | 221 | None | 40% | $338,032 |
| 2020 | 909 | 215 | 0% (0) | 34% | $258,822 |
| 2019 | 997 | 242 | None | 32% | $271,134 |
| 2018 | 985 | 242 | None | 28% | $233,067 |
| 2017 | 999 | 229 | 2% (23) | 25% | $198,960 |
| 2016 | 893 | 213 | None | 23% | $160,879 |
| 2015 | 871 | 186 | None | None | $91,584 |
| 2014 | 766 | 147 | 3% (20) | None | $78,001 |
| 2013 | 382 | 92 | 4% (14) | None | $30,050 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Myrbetriq | 272 | $341,132 | $1,254 |
| Gemtesa | 28 | $34,119 | $1,219 |
| Oxybutynin Chloride Er | 252 | $15,765 | $63 |
| Tolterodine Tartrate Er | 44 | $12,435 | $283 |
| Potassium Citrate Er | 19 | $5,951 | $313 |
| Renacidin | 25 | $4,220 | $169 |
| Tamsulosin | 72 | $2,049 | $28 |
| Nitrofurantoin | 27 | $1,492 | $55 |
| Trospium Chloride | 21 | $1,415 | $67 |
| Finasteride | 32 | $1,026 | $32 |
| Neomycin-Polymyxin B | 21 | $613 | $29 |
| Cephalexin | 15 | $172 | $11 |
| Sulfamethoxazole-Trimethoprim | 12 | $103 | $9 |
2022: 12 drugs
| Myrbetriq | 266 | $295,642 | $1,111 |
| Oxybutynin Chloride Er | 247 | $17,243 | $70 |
| Renacidin | 28 | $8,244 | $294 |
| Tolterodine Tartrate Er | 31 | $6,749 | $218 |
| Nitrofurantoin | 33 | $2,590 | $78 |
| Trospium Chloride | 15 | $1,975 | $132 |
| Potassium Citrate Er | 11 | $1,894 | $172 |
| Tamsulosin | 69 | $1,446 | $21 |
| Finasteride | 25 | $535 | $21 |
| Oxybutynin Chloride | 14 | $534 | $38 |
| Cephalexin | 27 | $350 | $13 |
| Sulfamethoxazole-Trimethoprim | 12 | $230 | $19 |
2021: 13 drugs
| Myrbetriq | 257 | $279,234 | $1,087 |
| Oxybutynin Chloride Er | 237 | $12,382 | $52 |
| Renacidin | 39 | $10,345 | $265 |
| Tolterodine Tartrate Er | 35 | $8,635 | $247 |
| Potassium Citrate Er | 19 | $4,308 | $227 |
| Nitrofurantoin | 26 | $1,698 | $65 |
| Tamsulosin | 82 | $1,378 | $17 |
| Oxybutynin Chloride | 15 | $671 | $45 |
| Solifenacin | 13 | $663 | $51 |
| Finasteride | 33 | $630 | $19 |
| Sodium Chloride | 23 | $263 | $11 |
| Cephalexin | 26 | $253 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $218 | $11 |
2020: 15 drugs
| Myrbetriq | 198 | $201,941 | $1,020 |
| Oxybutynin Chloride Er | 247 | $13,836 | $56 |
| Renacidin | 31 | $6,332 | $204 |
| Tolterodine Tartrate Er | 41 | $5,925 | $145 |
| Potassium Citrate Er | 18 | $5,446 | $303 |
| Solifenacin | 18 | $1,644 | $91 |
| Nitrofurantoin | 30 | $1,164 | $39 |
| Tamsulosin | 85 | $1,075 | $13 |
| Finasteride | 37 | $711 | $19 |
| Oxybutynin Chloride | 11 | $571 | $52 |
| Nitrofurantoin Mono-Macro | 17 | $305 | $18 |
| Sodium Chloride | 26 | $256 | $10 |
| Amitriptyline | 12 | $230 | $19 |
| Sulfamethoxazole-Trimethoprim | 25 | $130 | $5 |
| Cephalexin | 19 | $119 | $6 |
2019: 15 drugs
| Myrbetriq | 237 | $205,022 | $865 |
| Oxybutynin Chloride Er | 302 | $15,203 | $50 |
| Tolterodine Tartrate Er | 39 | $7,048 | $181 |
| Trospium Chloride Er | 14 | $4,511 | $322 |
| Renacidin | 12 | $3,392 | $283 |
| Potassium Citrate Er | 15 | $2,715 | $181 |
| Tamsulosin | 104 | $1,656 | $16 |
| Finasteride | 45 | $1,072 | $24 |
| Nitrofurantoin | 17 | $929 | $55 |
| Neomycin-Polymyxin B | 29 | $866 | $30 |
| Oxybutynin Chloride | 12 | $705 | $59 |
| Nitrofurantoin Mono-Macro | 11 | $256 | $23 |
| Cephalexin | 17 | $218 | $13 |
| Sodium Chloride | 21 | $203 | $10 |
| Sulfamethoxazole-Trimethoprim | 24 | $175 | $7 |
2018: 12 drugs
| Myrbetriq | 196 | $153,749 | $784 |
| Vesicare | 21 | $20,444 | $974 |
| Oxybutynin Chloride Er | 290 | $20,001 | $69 |
| Tolterodine Tartrate Er | 38 | $10,807 | $284 |
| Potassium Citrate Er | 25 | $4,862 | $194 |
| Renacidin | 19 | $3,880 | $204 |
| Tamsulosin | 135 | $2,465 | $18 |
| Oxybutynin Chloride | 18 | $920 | $51 |
| Finasteride | 43 | $821 | $19 |
| Neomycin-Polymyxin B | 21 | $773 | $37 |
| Sulfamethoxazole-Trimethoprim | 32 | $184 | $6 |
| Hydrochlorothiazide | 13 | $63 | $5 |
2017: 16 drugs
| Myrbetriq | 148 | $108,094 | $730 |
| Oxybutynin Chloride Er | 353 | $23,607 | $67 |
| Vesicare | 27 | $23,058 | $854 |
| Tolterodine Tartrate Er | 33 | $10,339 | $313 |
| Potassium Citrate Er | 28 | $5,859 | $209 |
| Renacidin | 18 | $4,876 | $271 |
| Tamsulosin | 89 | $2,011 | $23 |
| Neomycin-Polymyxin B | 37 | $1,436 | $39 |
| Oxybutynin Chloride | 23 | $1,415 | $62 |
| Nitrofurantoin | 16 | $1,020 | $64 |
| Finasteride | 36 | $674 | $19 |
| Amitriptyline | 19 | $638 | $34 |
| Sulfamethoxazole-Trimethoprim | 30 | $238 | $8 |
| Hydrocodone-Acetaminophen | 20 | $120 | $6 |
| Cephalexin | 12 | $54 | $5 |
| Hydrochlorothiazide | 12 | $37 | $3 |
2016: 17 drugs
| Myrbetriq | 97 | $61,727 | $636 |
| Oxybutynin Chloride Er | 320 | $21,997 | $69 |
| Vesicare | 32 | $18,385 | $575 |
| Tolterodine Tartrate Er | 12 | $4,428 | $369 |
| Estrace | 12 | $3,280 | $273 |
| Tamsulosin | 101 | $2,867 | $28 |
| Renacidin | 18 | $1,809 | $100 |
| Nitrofurantoin | 21 | $1,450 | $69 |
| Dutasteride | 13 | $1,258 | $97 |
| Neomycin-Polymyxin B | 25 | $1,008 | $40 |
| Oxybutynin Chloride | 25 | $989 | $40 |
| Amitriptyline | 21 | $814 | $39 |
| Finasteride | 33 | $672 | $20 |
| Polyethylene Glycol 3350 | 11 | $414 | $38 |
| Sulfamethoxazole-Trimethoprim | 33 | $322 | $10 |
| Cephalexin | 13 | $156 | $12 |
| Sodium Chloride | 12 | $91 | $8 |
2015: 19 drugs
| Myrbetriq | 61 | $20,673 | $339 |
| Oxybutynin Chloride Er | 267 | $19,614 | $73 |
| Vesicare | 52 | $15,614 | $300 |
| Avodart | 15 | $5,016 | $334 |
| Tolterodine Tartrate Er | 15 | $4,087 | $272 |
| Tamsulosin | 127 | $4,015 | $32 |
| Premarin | 12 | $3,024 | $252 |
| Renacidin | 23 | $1,180 | $51 |
| Neomycin-Polymyxin B | 25 | $1,151 | $46 |
| Nitrofurantoin | 16 | $1,097 | $69 |
| Finasteride | 46 | $992 | $22 |
| Oxybutynin Chloride | 16 | $755 | $47 |
| Amitriptyline | 22 | $568 | $26 |
| Polyethylene Glycol 3350 | 13 | $457 | $35 |
| Nitrofurantoin Mono-Macro | 13 | $432 | $33 |
| Sodium Chloride | 31 | $261 | $8 |
| Cephalexin | 11 | $166 | $15 |
| Sulfamethoxazole-Trimethoprim | 22 | $135 | $6 |
| Ciprofloxacin | 14 | $101 | $7 |
2014: 17 drugs
| Myrbetriq | 66 | $16,693 | $253 |
| Oxybutynin Chloride Er | 207 | $15,335 | $74 |
| Vesicare | 64 | $14,547 | $227 |
| Avodart | 13 | $5,287 | $407 |
| Enablex | 16 | $3,945 | $247 |
| Trospium Chloride | 16 | $2,346 | $147 |
| Tamsulosin | 95 | $1,876 | $20 |
| Renacidin | 16 | $1,014 | $63 |
| Oxybutynin Chloride | 14 | $826 | $59 |
| Nitrofurantoin | 14 | $774 | $55 |
| Finasteride | 34 | $456 | $13 |
| Sulfamethoxazole-Trimethoprim | 36 | $251 | $7 |
| Amitriptyline | 15 | $227 | $15 |
| Hydromorphone | 15 | $146 | $10 |
| Ciprofloxacin | 16 | $139 | $9 |
| Cephalexin | 14 | $93 | $7 |
| Sodium Chloride | 17 | $88 | $5 |
2013: 9 drugs
| Oxybutynin Chloride Er | 120 | $9,427 | $79 |
| Vesicare | 16 | $4,134 | $258 |
| Myrbetriq | 11 | $2,882 | $262 |
| Gelnique | 11 | $1,554 | $141 |
| Tamsulosin | 39 | $703 | $18 |
| Finasteride | 28 | $665 | $24 |
| Doxazosin Mesylate | 11 | $148 | $13 |
| Sodium Chloride | 13 | $144 | $11 |
| Ciprofloxacin | 17 | $92 | $5 |
Money from drug and device companies
$144 in 2025
| 2025 | 1 | 1 | None | $144 |
| 2024 | 4 | 15 | $430 | $2,003 |
| 2022 | 1 | 2 | $650 | $650 |
| 2021 | 2 | 2 | None | $91 |
| 2020 | 1 | 1 | None | $68 |
| 2019 | 2 | 2 | None | $164 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Interstim | $144 | 1 payment
|
See the published payment
| Medtronic | Meals · 2025-11-04 | Interstim | $144 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $2,003
| Bluewind Medical | Revi | $1,322 | 9 payments
|
| Stryker | None | $430 | 1 payment
|
| Coloplast | Altis | $211 | 4 payments
|
| Boston Scientific | Solyx Sis System | $41 | 1 payment
|
2022: $650
| C. R. Bard Inc. & Subsidiaries | None | $650 | 2 payments
|
2021: $91
| Astellas Pharma US | Xtandi | $70 | 1 payment
|
| 180 Medical | Gentlecath | $21 | 1 payment
|
2020: $68
| Allergan | Botox Cosmetic | $68 | 1 payment
|
2019: $164
| Medtronic USA | Interstim | $141 | 1 payment
|
| Allergan | Botox | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1609063262
- Licence
- CA A94018California A94018: Current · expires 2027-07-31
- Trained
- Ohio State University College of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Federal specialty code 2088F0040X (2088F0040X)
- Mailing address
- 165 Town Square Dr, Mountain View, CA, 94043
- NPI first listed
- 2007-09-27
- NPI last updated
- 2024-07-22
- NPI record certified
- 2024-07-22
This is when the NPI record was last certified, not a medical board exam.